In particular, the FGFR1 locus (8q12) has been found to be amplified in nearly 15% of hormone receptor (HR)-positive breast cancer and in approximately 5% of the aggressive triple-negative breast cancer (TNBC) [40]. Here, FGFR1 is linked to breast carcinoma.